03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Massachusetts law permits employers to pay inside salespeople on a commission only basis, provided t...
Read More >
While COVID shut the window on deals in H1 2020, Q3 saw a revival that augurs well for the rest of t...
Read More >
Whether accepting representations and warranties risk as a buyer or insurer, pay attention to the se...
Read More >
Spending Bill Extends EB-5 Regional Center Program, Includes Immigration Provisions - Congress has ...
Read More >
The IRS recently released final regulations making a number of changes to the rules applicable to ha...
Read More >
An institution’s trade secrets generally include confidential information with commercial value. Tr...
Read More >